Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
-
Published:2021-11-25
Issue:1
Volume:12
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Álvarez Eva G.ORCID, Demeulemeester JonasORCID, Otero PaulaORCID, Jolly Clemency, García-Souto DanielORCID, Pequeño-Valtierra Ana, Zamora Jorge, Tojo Marta, Temes JavierORCID, Baez-Ortega Adrian, Rodriguez-Martin BernardoORCID, Oitaben AnaORCID, Bruzos Alicia L.ORCID, Martínez-Fernández Mónica, Haase KerstinORCID, Zumalave SoniaORCID, Abal Rosanna, Rodríguez-Castro JorgeORCID, Rodriguez-Casanova AitorORCID, Diaz-Lagares Angel, Li Yilong, Raine Keiran M.ORCID, Butler Adam P., Otero IagoORCID, Ono Atsushi, Aikata Hiroshi, Chayama Kazuaki, Ueno Masaki, Hayami Shinya, Yamaue Hiroki, Maejima Kazuhiro, Blanco Miguel G.ORCID, Forns Xavier, Rivas Carmen, Ruiz-Bañobre JuanORCID, Pérez-del-Pulgar SofíaORCID, Torres-Ruiz RaúlORCID, Rodriguez-Perales SandraORCID, Garaigorta UrtziORCID, Campbell Peter J.ORCID, Nakagawa Hidewaki, Van Loo PeterORCID, Tubio Jose M. C.ORCID
Abstract
AbstractMost cancers are characterized by the somatic acquisition of genomic rearrangements during tumour evolution that eventually drive the oncogenesis. Here, using multiplatform sequencing technologies, we identify and characterize a remarkable mutational mechanism in human hepatocellular carcinoma caused by Hepatitis B virus, by which DNA molecules from the virus are inserted into the tumour genome causing dramatic changes in its configuration, including non-homologous chromosomal fusions, dicentric chromosomes and megabase-size telomeric deletions. This aberrant mutational mechanism, present in at least 8% of all HCC tumours, can provide the driver rearrangements that a cancer clone requires to survive and grow, including loss of relevant tumour suppressor genes. Most of these events are clonal and occur early during liver cancer evolution. Real-time timing estimation reveals some HBV-mediated rearrangements occur as early as two decades before cancer diagnosis. Overall, these data underscore the importance of characterising liver cancer genomes for patterns of HBV integration.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference49 articles.
1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018). 2. Midorikawa, Y. et al. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene 25, 5581–5590 (2006). 3. Wong, N. et al. A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping. Hepatology 32, 1060–1068 (2000). 4. Meyer, M., Wiedorn, K. H., Hofschneider, P. H., Koshy, R. & Caselmann, W. H. A chromosome 17:7 translocation is associated with a hepatitis B virus DNA integration in human hepatocellular carcinoma DNA. Hepatology 15, 665–671 (1992). 5. Meng, G. et al. TSD: a computational tool to study the complex structural variants using PacBio targeted sequencing data. G3 9, 1371–1376 (2019).
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|